Twit­ter ad­ver­tis­ing pause or per­sist? Phar­mas qui­et­ly weigh op­tions in un­cer­tain time

As Elon Musk’s takeover of Twit­ter — and al­most-dai­ly con­tro­ver­sies — caus­es con­fu­sion and con­ster­na­tion, brand ad­ver­tis­ers on the plat­form are try­ing to fig­ure out what to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER